Autologous umbilical cord blood mononuclear cell therapy for hypoplastic left heart syndrome: a nonrandomized control trial of the efficacy and safety of intramyocardial injections.
Saved in:
| Title: | Autologous umbilical cord blood mononuclear cell therapy for hypoplastic left heart syndrome: a nonrandomized control trial of the efficacy and safety of intramyocardial injections. |
|---|---|
| Authors: | Gallego-Navarro C; Division of Cardiovascular Diseases, Center for Regenerative Medicine, Mayo Clinic, Rochester, MN, USA.; Program for Hypoplastic Left Heart Syndrome, Mayo Clinic Rochester, Rochester, MN, USA., Jaggers J; Division of Congenital Heart Surgery, Heart Institute, Children's Hospital Colorado, University of Colorado Denver Anschutz Medical Campus, Denver, CO, USA., Burkhart HM; Division of Cardiac, Thoracic and Vascular Surgery, University of Oklahoma Health Sciences, Oklahoma, USA., Carlo WF; Division of Pediatric Cardiology, University of Alabama Birmingham, Birmingham, AL, USA., Morales DL; Division of Congenital Heart Surgery, Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Qureshi MY; Program for Hypoplastic Left Heart Syndrome, Mayo Clinic Rochester, Rochester, MN, USA.; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA., Rossano JW; Department of Pediatrics, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, USA., Hagen CE; HeartWorks Inc. Rochester, Rochester, MN, USA., Seisler DK; Program for Hypoplastic Left Heart Syndrome, Mayo Clinic Rochester, Rochester, MN, USA., Peral SC; Division of Cardiovascular Diseases, Center for Regenerative Medicine, Mayo Clinic, Rochester, MN, USA.; Program for Hypoplastic Left Heart Syndrome, Mayo Clinic Rochester, Rochester, MN, USA., Nelson TJ; Division of Cardiovascular Diseases, Center for Regenerative Medicine, Mayo Clinic, Rochester, MN, USA. Nelson.Timothy@mayo.edu.; Program for Hypoplastic Left Heart Syndrome, Mayo Clinic Rochester, Rochester, MN, USA. Nelson.Timothy@mayo.edu.; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA. Nelson.Timothy@mayo.edu.; HeartWorks Inc. Rochester, Rochester, MN, USA. Nelson.Timothy@mayo.edu.; General Internal Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Center for Regenerative Medicine, Mayo Clinic, Rochester, MN, USA. Nelson.Timothy@mayo.edu. |
| Source: | Stem cell research & therapy [Stem Cell Res Ther] 2025 May 01; Vol. 16 (1), pp. 215. Date of Electronic Publication: 2025 May 01. |
| Publication Type: | Clinical Trial, Phase II; Controlled Clinical Trial; Journal Article; Multicenter Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-6512 (Electronic) Linking ISSN: 17576512 NLM ISO Abbreviation: Stem Cell Res Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1757-6512 |
|---|---|
| DOI: | 10.1186/s13287-025-04316-3 |
